These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24370587)

  • 1. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
    Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats.
    Zang L; Gao F; Huang A; Zhang Y; Luo Y; Chen L; Mao N
    J Pharmacol Sci; 2022 Feb; 148(2):204-213. PubMed ID: 35063135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
    Zhang W; Miao J; Ma C; Han D; Zhang Y
    Peptides; 2012 Aug; 36(2):186-91. PubMed ID: 22687367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
    Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
    Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tongxinluo Inhibits Renal Fibrosis in Diabetic Nephropathy: Involvement of the Suppression of Intercellular Transfer of TGF-[Formula: see text]1-Containing Exosomes from GECs to GMCs.
    Wu XM; Gao YB; Xu LP; Zou DW; Zhu ZY; Wang XL; Yao WJ; Luo LT; Tong Y; Tian NX; Han ZJ; Dang WY
    Am J Chin Med; 2017; 45(5):1075-1092. PubMed ID: 28659030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR‑192, a Smad3-dependent microRNA.
    Hong JP; Li XM; Li MX; Zheng FL
    Int J Mol Med; 2013 Jun; 31(6):1436-42. PubMed ID: 23588932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy.
    Xiaobing L; Chunling N; Wenyu C; Yan C; Zhenzhen L
    Curr Pharm Biotechnol; 2020; 21(12):1204-1212. PubMed ID: 32297575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
    Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
    Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
    Ma J; Zhang L; Hao J; Li N; Tang J; Hao L
    J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated miR-15a mediates the epithelial-mesenchymal transition in renal tubular epithelial cells promoted by high glucose.
    Sun T; Yang J; Dong W; Wang R; Ma P; Kang P; Zhang H; Xie C; Du J; Zhao L
    Biosci Biotechnol Biochem; 2014; 78(8):1363-70. PubMed ID: 25130738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
    Gao BH; Wu H; Wang X; Ji LL; Chen C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Chinese Medicine Tong xinluo on Diabetic Nephropathy via Inhibiting TGF- β 1-Induced Epithelial-to-Mesenchymal Transition.
    Zhang N; Gao Y; Zou D; Wang J; Li J; Zhou S; Zhu Z; Zhao X; Xu L; Zhang H
    Evid Based Complement Alternat Med; 2014; 2014():123497. PubMed ID: 24864150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.